Product

Botulinum Toxin Type A

Aliases
AbobotulinumtoxinA, Botox, Botox®, BOTOX®, Botox Cosmetic (14 other aliases)
Name
BOTOX Cosmetic
INN Name
onabotulinumtoxinA
FDA Approved
Yes

12 clinical trials

1 organization

16 indications

1 document

Indication
Frown Lines
Indication
Crow's feet
Indication
Crow's Feet
Indication
Acne Rosacea
Indication
Botulism
Indication
Migraine
Indication
Cerebral Palsy
Clinical trial
Clinical Trial to Evaluate ET-01 in Subjects With Lateral Canthal Lines
Status: Active (not recruiting), Estimated PCD: 2024-04-01
Clinical trial
2015H0024
Status: Completed, Estimated PCD: 2022-06-01
Clinical trial
The Efficacy of Botulinum Toxin Type a in Treating Peyronie's Disease
Status: Completed, Estimated PCD: 2017-02-15
Organization
Allergan, Inc.